Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Short-term Investments (2016 - 2025)

Bio-Techne has reported Short-term Investments over the past 16 years, most recently at $2.8 million for Q2 2025.

  • Quarterly results put Short-term Investments at $2.8 million for Q2 2025, up 165.21% from a year ago — trailing twelve months through Jun 2025 was $2.8 million (up 165.21% YoY), and the annual figure for FY2025 was $2.8 million, up 165.21%.
  • Short-term Investments for Q2 2025 was $2.8 million at Bio-Techne, down from $3.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for TECH hit a ceiling of $90.1 million in Q1 2021 and a floor of $1.1 million in Q2 2024.
  • Median Short-term Investments over the past 5 years was $23.7 million (2023), compared with a mean of $28.0 million.
  • Biggest five-year swings in Short-term Investments: plummeted 95.48% in 2024 and later soared 165.21% in 2025.
  • Bio-Techne's Short-term Investments stood at $67.1 million in 2021, then plummeted by 52.22% to $32.1 million in 2022, then crashed by 82.79% to $5.5 million in 2023, then tumbled by 41.54% to $3.2 million in 2024, then decreased by 11.9% to $2.8 million in 2025.
  • The last three reported values for Short-term Investments were $2.8 million (Q2 2025), $3.2 million (Q4 2024), and $6.7 million (Q3 2024) per Business Quant data.